{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T16:30:44Z","timestamp":1774024244017,"version":"3.50.1"},"reference-count":214,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:00:00Z","timestamp":1623369600000},"content-version":"vor","delay-in-days":161,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DP1DA037979"],"award-info":[{"award-number":["DP1DA037979"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01AI128782"],"award-info":[{"award-number":["R01AI128782"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01AI138718"],"award-info":[{"award-number":["R01AI138718"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R56DK119940"],"award-info":[{"award-number":["R56DK119940"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI120712"],"award-info":[{"award-number":["R01AI120712"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["RO1DK112254"],"award-info":[{"award-number":["RO1DK112254"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Immunology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.smim.2021.101482","type":"journal-article","created":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T04:18:01Z","timestamp":1623298681000},"page":"101482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Microbial mismanagement: how inadequate treatments for vaginal dysbiosis drive the HIV epidemic in women"],"prefix":"10.1016","volume":"51","author":[{"given":"Andrew","family":"Gustin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6386-615X","authenticated-orcid":false,"given":"Ross","family":"Cromarty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6123-536X","authenticated-orcid":false,"given":"Luca","family":"Schifanella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nichole R.","family":"Klatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.smim.2021.101482_bib0005","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1084\/jem.20161289","article-title":"Dampened antiviral immunity to intravaginal exposure to RNA viral pathogens allows enhanced viral replication","volume":"213","author":"Khan","year":"2016","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.smim.2021.101482_bib0010","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1600-0897.2010.00842.x","article-title":"Sex hormone regulation of innate immunity in the female reproductive tract: the role of epithelial cells in balancing reproductive potential with protection against sexually transmitted pathogens","volume":"63","author":"Wira","year":"2010","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.smim.2021.101482_bib0015","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.0105-2896.2005.00287.x","article-title":"Innate and adaptive immunity in female genital tract: cellular responses and interactions","volume":"206","author":"Wira","year":"2005","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.smim.2021.101482_bib0020","volume":"vol. 6","author":"Major Infectious Diseases","year":"2017"},{"key":"10.1016\/j.smim.2021.101482_bib0025","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.anaerobe.2017.05.005","article-title":"Susceptibility of bacterial vaginosis (BV)-associated bacteria to secnidazole compared to metronidazole, tinidazole and clindamycin","volume":"47","author":"Petrina","year":"2017","journal-title":"Anaerobe"},{"issue":"3","key":"10.1016\/j.smim.2021.101482_bib0030","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nm.4485","article-title":"Congenital Zika virus infection as a silent pathology with loss of neurogenic output in the fetal brain","volume":"24","author":"Adams Waldorf","year":"2018","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.smim.2021.101482_bib0035","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.immuni.2015.04.019","article-title":"Cervicovaginal bacteria are a major modulator of host inflammatory responses in the female genital tract","volume":"42","author":"Anahtar","year":"2015","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.smim.2021.101482_bib0040","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.immuni.2016.12.013","article-title":"Lactobacillus-deficient cervicovaginal bacterial communities are associated with increased HIV acquisition in young South African Women","volume":"46","author":"Gosmann","year":"2017","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.smim.2021.101482_bib0045","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.1128\/JVI.00099-16","article-title":"Effects of fecal microbial transplantation on microbiome and immunity in simian immunodeficiency virus-infected macaques","volume":"90","author":"Hensley-McBain","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2021.101482_bib0050","series-title":"HIV and Women","author":"CDC","year":"2021"},{"issue":"4","key":"10.1016\/j.smim.2021.101482_bib0055","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00002030-200303070-00001","article-title":"Recent observations on HIV type-1 infection in the genital tract of men and women","volume":"17","author":"Coombs","year":"2003","journal-title":"AIDS"},{"issue":"Suppl. 4","key":"10.1016\/j.smim.2021.101482_bib0060","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1097\/01.aids.0000390704.35642.47","article-title":"Treatment of sexually transmitted infections for HIV prevention: end of the road or new beginning?","volume":"24","author":"Hayes","year":"2010","journal-title":"AIDS"},{"issue":"8","key":"10.1016\/j.smim.2021.101482_bib0065","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/cid\/cit437","article-title":"HIV incidence among men with and those without sexually transmitted rectal infections: estimates from matching against an HIV case registry","volume":"57","author":"Pathela","year":"2013","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.smim.2021.101482_bib0070","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1177\/003335491412900210","article-title":"High risk for HIV following syphilis diagnosis among men in Florida, 2000\u20132011","volume":"129","author":"Peterman","year":"2014","journal-title":"Public Health Rep."},{"issue":"3","key":"10.1016\/j.smim.2021.101482_bib0075","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/OLQ.0000000000000420","article-title":"Willingness to disclose sexually transmitted infection status to sex partners among college-aged men in the United States","volume":"43","author":"Pfeiffer","year":"2016","journal-title":"Sex. Transm. Dis."},{"issue":"Suppl. 3","key":"10.1016\/j.smim.2021.101482_bib0080","doi-asserted-by":"crossref","first-page":"S616","DOI":"10.1093\/infdis\/jiu459","article-title":"Vaginal microbiota and sexually transmitted infections that may influence transmission of cell-associated HIV","volume":"210","author":"Cone","year":"2014","journal-title":"J. Infect. Dis."},{"issue":"10","key":"10.1016\/j.smim.2021.101482_bib0085","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1093\/cid\/ciy762","article-title":"Impact of standard bacterial vaginosis treatment on the genital microbiota, immune milieu, and ex vivo human immunodeficiency virus susceptibility","volume":"68","author":"Joag","year":"2019","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.smim.2021.101482_bib0090","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/1574-6976.12029","article-title":"Vaginal microbiota and its role in HIV transmission and infection","volume":"37","author":"Petrova","year":"2013","journal-title":"FEMS Microbiol. Rev."},{"issue":"3","key":"10.1016\/j.smim.2021.101482_bib0095","first-page":"160","article-title":"[Vaginal microbiota: composition, protective role, associated pathologies, and therapeutic perspectives]","volume":"26","author":"Martin","year":"2008","journal-title":"Enferm. Infecc. Microbiol. Clin."},{"issue":"1\u20132","key":"10.1016\/j.smim.2021.101482_bib0100","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0165-0378(02)00019-0","article-title":"The innate and early immune response to pathogen challenge in the female genital tract and the pivotal role of epithelial cells","volume":"57","author":"Quayle","year":"2002","journal-title":"J. Reprod. Immunol."},{"issue":"4","key":"10.1016\/j.smim.2021.101482_bib0105","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1095\/biolreprod56.4.999","article-title":"Mucin genes expressed by human female reproductive tract epithelia","volume":"56","author":"Gipson","year":"1997","journal-title":"Biol. Reprod."},{"issue":"1","key":"10.1016\/j.smim.2021.101482_bib0110","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/jmicro\/dfn032","article-title":"Scanning electron and light microscopy study of the cervical mucus in women with polycystic ovary syndrome","volume":"58","author":"Vigil","year":"2009","journal-title":"J. Electron Microsc. (Tokyo)"},{"issue":"5","key":"10.1016\/j.smim.2021.101482_bib0115","doi-asserted-by":"crossref","first-page":"e01084","DOI":"10.1128\/mBio.01084-15","article-title":"Enhanced Trapping of HIV-1 by human cervicovaginal mucus is associated with Lactobacillus crispatus-dominant microbiota","volume":"6","author":"Nunn","year":"2015","journal-title":"mBio"},{"key":"10.1016\/j.smim.2021.101482_bib0120","series-title":"Textbook of Aging Skin","author":"Farage","year":"2009"},{"issue":"3","key":"10.1016\/j.smim.2021.101482_bib0125","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.fertnstert.2018.06.036","article-title":"Cervicovaginal microbiota, women\u2019s health, and reproductive outcomes","volume":"110","author":"Kroon","year":"2018","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.smim.2021.101482_bib0130","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1146\/annurev-micro-092611-150157","article-title":"Vaginal microbiome: rethinking health and disease","volume":"66","author":"Ma","year":"2012","journal-title":"Annu. Rev. Microbiol."},{"issue":"6","key":"10.1016\/j.smim.2021.101482_bib0135","doi-asserted-by":"crossref","first-page":"E762","DOI":"10.1073\/pnas.1518589113","article-title":"Dysbiosis-induced IL-33 contributes to impaired antiviral immunity in the genital mucosa","volume":"113","author":"Oh","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.smim.2021.101482_bib0140","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1177\/1933719115581000","article-title":"Alpha-amylase in vaginal fluid: association with conditions favorable to dominance of Lactobacillus","volume":"22","author":"Nasioudis","year":"2015","journal-title":"Reprod. Sci."},{"issue":"7","key":"10.1016\/j.smim.2021.101482_bib0145","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/infdis\/jiu231","article-title":"Human alpha-amylase present in lower-genital-tract mucosal fluid processes glycogen to support vaginal colonization by Lactobacillus","volume":"210","author":"Spear","year":"2014","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.smim.2021.101482_bib0150","doi-asserted-by":"crossref","first-page":"e0224359","DOI":"10.1371\/journal.pone.0224359","article-title":"Aberrant cervical innate immunity predicts onset of dysbiosis and sexually transmitted infections in women of reproductive age","volume":"15","author":"Fichorova","year":"2020","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.smim.2021.101482_bib0155","doi-asserted-by":"crossref","first-page":"e1001251","DOI":"10.1371\/journal.pmed.1001251","article-title":"Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples","volume":"9","author":"Cohen","year":"2012","journal-title":"PLoS Med."},{"issue":"12","key":"10.1016\/j.smim.2021.101482_bib0160","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1097\/QAD.0b013e3283021a37","article-title":"Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies","volume":"22","author":"Atashili","year":"2008","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.smim.2021.101482_bib0165","doi-asserted-by":"crossref","first-page":"e1000416","DOI":"10.1371\/journal.pmed.1000416","article-title":"Intravaginal practices, bacterial vaginosis, and HIV infection in women: individual participant data meta-analysis","volume":"8","author":"Low","year":"2011","journal-title":"PLoS Med."},{"issue":"5","key":"10.1016\/j.smim.2021.101482_bib0170","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1365-2672.2011.04977.x","article-title":"The aetiology of bacterial vaginosis","volume":"110","author":"Turovskiy","year":"2011","journal-title":"J. Appl. Microbiol."},{"issue":"3","key":"10.1016\/j.smim.2021.101482_bib0175","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/0956462417723546","article-title":"Influencing the importance of health, partners, and hygiene among Zambian women","volume":"29","author":"Rodriguez","year":"2018","journal-title":"Int. J. STD AIDS"},{"issue":"1","key":"10.1016\/j.smim.2021.101482_bib0180","doi-asserted-by":"crossref","first-page":"e0191625","DOI":"10.1371\/journal.pone.0191625","article-title":"Associations between sexual habits, menstrual hygiene practices, demographics and the vaginal microbiome as revealed by Bayesian network analysis","volume":"13","author":"Noyes","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.smim.2021.101482_bib0185","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0002-9378(90)90839-Y","article-title":"Statistical evaluation of diagnostic criteria for bacterial vaginosis","volume":"162","author":"Thomason","year":"1990","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.smim.2021.101482_bib0190","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1128\/jcm.29.2.297-301.1991","article-title":"Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation","volume":"29","author":"Nugent","year":"1991","journal-title":"J. Clin. Microbiol."},{"issue":"8","key":"10.1016\/j.smim.2021.101482_bib0195","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1128\/jcm.29.8.1730-1731.1991","article-title":"Reproducibility of a scoring system for gram stain diagnosis of bacterial vaginosis","volume":"29","author":"Joesoef","year":"1991","journal-title":"J. Clin. Microbiol."},{"issue":"3","key":"10.1016\/j.smim.2021.101482_bib0200","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1089\/aid.2018.0304","article-title":"The evolving facets of bacterial vaginosis: implications for HIV transmission","volume":"35","author":"McKinnon","year":"2019","journal-title":"AIDS Res. Hum. Retroviruses"},{"issue":"4","key":"10.1016\/j.smim.2021.101482_bib0205","doi-asserted-by":"crossref","first-page":"e10197","DOI":"10.1371\/journal.pone.0010197","article-title":"Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis","volume":"5","author":"Srinivasan","year":"2010","journal-title":"PLoS One"},{"issue":"132","key":"10.1016\/j.smim.2021.101482_bib0210","doi-asserted-by":"crossref","first-page":"132ra52","DOI":"10.1126\/scitranslmed.3003605","article-title":"Temporal dynamics of the human vaginal microbiota","volume":"4","author":"Gajer","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.smim.2021.101482_bib0215","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1128\/CMR.00075-15","article-title":"The human microbiome during bacterial vaginosis","volume":"29","author":"Onderdonk","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.smim.2021.101482_bib0220","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3389\/fphys.2015.00164","article-title":"Antimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosis","volume":"6","author":"Aldunate","year":"2015","journal-title":"Front. Physiol."},{"issue":"11","key":"10.1016\/j.smim.2021.101482_bib0225","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1089\/aid.2015.0006","article-title":"Bacterial vaginosis and subclinical markers of genital tract inflammation and mucosal immunity","volume":"31","author":"Thurman","year":"2015","journal-title":"AIDS Res. Hum. Retroviruses"},{"issue":"3","key":"10.1016\/j.smim.2021.101482_bib0230","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/mi.2015.86","article-title":"Cervicovaginal microbiome dysbiosis is associated with proteome changes related to alterations of the cervicovaginal mucosal barrier","volume":"9","author":"Borgdorff","year":"2016","journal-title":"Mucosal Immunol."},{"issue":"4","key":"10.1016\/j.smim.2021.101482_bib0235","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1089\/aid.2016.0187","article-title":"High levels of inflammatory cytokines in the reproductive tract of women with BV and engaging in intravaginal douching: a cross-sectional study of participants in the women interagency HIV study","volume":"33","author":"Alcaide","year":"2017","journal-title":"AIDS Res. Hum. Retroviruses"},{"issue":"6","key":"10.1016\/j.smim.2021.101482_bib0240","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/aji.12264","article-title":"Bacterial vaginosis and the cervicovaginal immune response","volume":"71","author":"Mitchell","year":"2014","journal-title":"Am. J. Reprod. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2021.101482_bib0245","doi-asserted-by":"crossref","first-page":"11974","DOI":"10.1038\/s41598-017-12198-6","article-title":"A longitudinal analysis of the vaginal microbiota and vaginal immune mediators in women from sub-Saharan Africa","volume":"7","author":"Jespers","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.smim.2021.101482_bib0250","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/sextrans-2015-052072","article-title":"Inflammatory cytokine biomarkers to identify women with asymptomatic sexually transmitted infections and bacterial vaginosis who are at high risk of HIV infection","volume":"92","author":"Masson","year":"2016","journal-title":"Sex. Transm. Infect."},{"issue":"15","key":"10.1016\/j.smim.2021.101482_bib0255","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1097\/QAD.0b013e328311ac65","article-title":"Genital levels of soluble immune factors with anti-HIV activity may correlate with increased HIV susceptibility","volume":"22","author":"Kaul","year":"2008","journal-title":"AIDS"},{"issue":"1 Suppl","key":"10.1016\/j.smim.2021.101482_bib0260","first-page":"e746","article-title":"Impact of human immunodeficiency virus 1 infection and inflammation on the composition and yield of cervical mononuclear cells in the female genital tract","volume":"128","author":"Nkwanyana","year":"2009","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.smim.2021.101482_bib0265","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/mi.2015.51","article-title":"Increased levels of inflammatory cytokines in the female reproductive tract are associated with altered expression of proteases, mucosal barrier proteins, and an influx of HIV-susceptible target cells","volume":"9","author":"Arnold","year":"2016","journal-title":"Mucosal Immunol."},{"issue":"9","key":"10.1016\/j.smim.2021.101482_bib0270","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/infdis\/jiu621","article-title":"Plasma cytokine levels and risk of HIV type 1 (HIV-1) transmission and acquisition: a nested case-control study among HIV-1-serodiscordant couples","volume":"211","author":"Kahle","year":"2015","journal-title":"J. Infect. Dis."},{"issue":"7","key":"10.1016\/j.smim.2021.101482_bib0275","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/infdis\/jis465","article-title":"Innate immune activation enhances hiv acquisition in women, diminishing the effectiveness of tenofovir microbicide gel","volume":"206","author":"Naranbhai","year":"2012","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.smim.2021.101482_bib0280","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/QAD.0b013e328321809c","article-title":"Levels of innate immune factors in genital fluids: association of alpha defensins and LL-37 with genital infections and increased HIV acquisition","volume":"23","author":"Levinson","year":"2009","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.smim.2021.101482_bib0285","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/cid\/civ298","article-title":"Genital inflammation and the risk of HIV acquisition in women","volume":"61","author":"Masson","year":"2015","journal-title":"Clin. Infect. Dis."},{"issue":"8","key":"10.1016\/j.smim.2021.101482_bib0290","doi-asserted-by":"crossref","first-page":"e43670","DOI":"10.1371\/journal.pone.0043670","article-title":"Blunted IL17\/IL22 and pro-inflammatory cytokine responses in the genital tract and blood of HIV-exposed, seronegative female sex workers in Kenya","volume":"7","author":"Chege","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.smim.2021.101482_bib0295","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/QAI.0b013e3182454fcd","article-title":"HIV controllers are distinguished by chemokine expression profile and HIV-specific T-cell proliferative potential","volume":"59","author":"Card","year":"2012","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"3","key":"10.1016\/j.smim.2021.101482_bib0300","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/mi.2012.7","article-title":"A distinct cytokine and chemokine profile at the genital mucosa is associated with HIV-1 protection among HIV-exposed seronegative commercial sex workers","volume":"5","author":"Lajoie","year":"2012","journal-title":"Mucosal Immunol."},{"issue":"Suppl. 3","key":"10.1016\/j.smim.2021.101482_bib0305","doi-asserted-by":"crossref","first-page":"S339","DOI":"10.1086\/655968","article-title":"HIV-exposed seronegative commercial sex workers show a quiescent phenotype in the CD4+ T cell compartment and reduced expression of HIV-dependent host factors","volume":"202","author":"McLaren","year":"2010","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.smim.2021.101482_bib0310","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/mi.2013.83","article-title":"Immune correlates of HIV exposure without infection in foreskins of men from Rakai, Uganda","volume":"7","author":"Prodger","year":"2014","journal-title":"Mucosal Immunol."},{"issue":"2","key":"10.1016\/j.smim.2021.101482_bib0315","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/mi.2013.44","article-title":"Acting locally: innate mucosal immunity in resistance to HIV-1 infection in Kenyan commercial sex workers","volume":"7","author":"Yao","year":"2014","journal-title":"Mucosal Immunol."},{"issue":"4","key":"10.1016\/j.smim.2021.101482_bib0320","doi-asserted-by":"crossref","first-page":"e1000852","DOI":"10.1371\/journal.ppat.1000852","article-title":"Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation","volume":"6","author":"Nazli","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.smim.2021.101482_bib0325","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1749-6632.2000.tb05242.x","article-title":"Epithelial barrier defects in HT-29\/B6 colonic cell monolayers induced by tumor necrosis factor-alpha","volume":"915","author":"Gitter","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.smim.2021.101482_bib0330","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1749-6632.2000.tb05255.x","article-title":"Effect of TNF alpha and IFN gamma on epithelial barrier function in rat rectum in vitro","volume":"915","author":"Grotjohann","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"Pt 11","key":"10.1016\/j.smim.2021.101482_bib0335","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1242\/jcs.113.11.2085","article-title":"Expression from the human occludin promoter is affected by tumor necrosis factor alpha and interferon gamma","volume":"113","author":"Mankertz","year":"2000","journal-title":"J. Cell. Sci."},{"issue":"2","key":"10.1016\/j.smim.2021.101482_bib0340","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1172\/JCI113938","article-title":"Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers","volume":"83","author":"Madara","year":"1989","journal-title":"J. Clin. Invest."},{"issue":"Pt 1","key":"10.1016\/j.smim.2021.101482_bib0345","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1242\/jcs.112.1.137","article-title":"Tumor necrosis factor-alpha (TNFalpha) regulates the epithelial barrier in the human intestinal cell line HT-29\/B6","volume":"112","author":"Schmitz","year":"1999","journal-title":"J. Cell. Sci."},{"issue":"7","key":"10.1016\/j.smim.2021.101482_bib0350","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1073\/pnas.86.7.2336","article-title":"Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B","volume":"86","author":"Osborn","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7241","key":"10.1016\/j.smim.2021.101482_bib0355","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/nature07831","article-title":"Glycerol monolaurate prevents mucosal SIV transmission","volume":"458","author":"Li","year":"2009","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.smim.2021.101482_bib0360","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/nm.2395","article-title":"Low levels of SIV infection in sooty mangabey central memory CD(4)(+) T cells are associated with limited CCR5 expression","volume":"17","author":"Paiardini","year":"2011","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.smim.2021.101482_bib0365","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/QAI.0000000000001218","article-title":"Genital-systemic chemokine gradients and the risk of HIV acquisition in women","volume":"74","author":"Liebenberg","year":"2017","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"5","key":"10.1016\/j.smim.2021.101482_bib0370","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nri3442","article-title":"The integration of T cell migration, differentiation and function","volume":"13","author":"Masopust","year":"2013","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.smim.2021.101482_bib0375","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.molimm.2004.06.016","article-title":"Role of cytokines and chemokines in the regulation of innate immunity and HIV infection","volume":"42","author":"Alfano","year":"2005","journal-title":"Mol. Immunol."},{"issue":"5","key":"10.1016\/j.smim.2021.101482_bib0380","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1189\/jlb.1102547","article-title":"The relative activity of CXCR3 and CCR5 ligands in T lymphocyte migration: concordant and disparate activities in vitro and in vivo","volume":"74","author":"Stanford","year":"2003","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.smim.2021.101482_bib0385","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1357-2725(03)00172-9","article-title":"The chemokine receptor, CCR5","volume":"36","author":"Mueller","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"2","key":"10.1016\/j.smim.2021.101482_bib0390","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/jlb.66.2.252","article-title":"Regulation of dendritic cell trafficking: a process that involves the participation of selective chemokines","volume":"66","author":"Dieu-Nosjean","year":"1999","journal-title":"J. Leukoc. Biol."},{"issue":"1\u20133","key":"10.1016\/j.smim.2021.101482_bib0395","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.febslet.2004.04.100","article-title":"CCL3, acting via the chemokine receptor CCR5, leads to independent activation of Janus kinase 2 (JAK2) and Gi proteins","volume":"570","author":"Mueller","year":"2004","journal-title":"FEBS Lett."},{"issue":"Pt 8","key":"10.1016\/j.smim.2021.101482_bib0400","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1242\/jcs.00963","article-title":"The JAK\/STAT signaling pathway","volume":"117","author":"Rawlings","year":"2004","journal-title":"J. Cell. Sci."},{"issue":"1","key":"10.1016\/j.smim.2021.101482_bib0405","first-page":"e24198","article-title":"STAT signaling in inflammation","volume":"2","author":"Kaplan","year":"2013","journal-title":"JAKSTAT"},{"issue":"23","key":"10.1016\/j.smim.2021.101482_bib0410","doi-asserted-by":"crossref","first-page":"12229","DOI":"10.1128\/JVI.01311-09","article-title":"Elevated levels of innate immune modulators in lymph nodes and blood are associated with more-rapid disease progression in simian immunodeficiency virus-infected monkeys","volume":"83","author":"Durudas","year":"2009","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.smim.2021.101482_bib0415","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/QAI.0000000000000891","article-title":"Blocking CXCL9 decreases HIV-1 replication and enhances the activity of prophylactic antiretrovirals in human cervical tissues","volume":"71","author":"Macura","year":"2016","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"45","key":"10.1016\/j.smim.2021.101482_bib0420","doi-asserted-by":"crossref","first-page":"30745","DOI":"10.1074\/jbc.M804112200","article-title":"CCL2 increases X4-tropic HIV-1 entry into resting CD4+ t cells","volume":"283","author":"Campbell","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.smim.2021.101482_bib0425","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1146\/annurev-immunol-042617-053309","article-title":"RIG-I and other RNA sensors in antiviral immunity","volume":"36","author":"Chow","year":"2018","journal-title":"Annu. Rev. Immunol."},{"issue":"7\u20138","key":"10.1016\/j.smim.2021.101482_bib0430","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00335-018-9755-6","article-title":"Interferon-stimulated genes: new platforms and computational approaches","volume":"29","author":"Green","year":"2018","journal-title":"Mamm. Genome"},{"issue":"11","key":"10.1016\/j.smim.2021.101482_bib0435","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms8111787","article-title":"The role of toll-like receptors in retroviral infection","volume":"8","author":"Browne","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.smim.2021.101482_bib0440","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.3389\/fimmu.2019.01705","article-title":"Diminished HIV infection of target CD4+ t cells in a toll-like receptor 4 stimulated in vitro model","volume":"10","author":"Cromarty","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2021.101482_bib0445","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12977-016-0316-3","article-title":"TLR7\/8 agonist induces a post-entry SAMHD1-independent block to HIV-1 infection of monocytes","volume":"13","author":"Hofmann","year":"2016","journal-title":"Retrovirology"},{"key":"10.1016\/j.smim.2021.101482_bib0450","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2334-12-5","article-title":"R-848 triggers the expression of TLR7\/8 and suppresses HIV replication in monocytes","volume":"12","author":"Nian","year":"2012","journal-title":"BMC Infect. Dis."},{"issue":"10","key":"10.1016\/j.smim.2021.101482_bib0455","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.1128\/IAI.00524-06","article-title":"Reversible deficiency of antimicrobial polypeptides in bacterial vaginosis","volume":"74","author":"Valore","year":"2006","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.smim.2021.101482_bib0460","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11904-007-0004-y","article-title":"Bacterial vaginosis and host immunity","volume":"4","author":"St John","year":"2007","journal-title":"Curr. HIV\/AIDS Rep."},{"issue":"1","key":"10.1016\/j.smim.2021.101482_bib0465","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejogrb.2012.11.008","article-title":"Altered CD16 expression on vaginal neutrophils from women with vaginitis","volume":"167","author":"Beghini","year":"2013","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"8","key":"10.1016\/j.smim.2021.101482_bib0470","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1177\/1933719115570914","article-title":"Neutrophil gelatinase-associated lipocalin concentration in vaginal fluid: relation to bacterial vaginosis and vulvovaginal candidiasis","volume":"22","author":"Beghini","year":"2015","journal-title":"Reprod. Sci."},{"issue":"4","key":"10.1016\/j.smim.2021.101482_bib0475","doi-asserted-by":"crossref","first-page":"e1007672","DOI":"10.1371\/journal.ppat.1007672","article-title":"Increased mucosal neutrophil survival is associated with altered microbiota in HIV infection","volume":"15","author":"Hensley-McBain","year":"2019","journal-title":"PLoS Pathog."},{"issue":"3","key":"10.1016\/j.smim.2021.101482_bib0480","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41385-019-0238-1","article-title":"Antibiotic-induced microbiome perturbations are associated with significant alterations to colonic mucosal immunity in rhesus macaques","volume":"13","author":"Manuzak","year":"2020","journal-title":"Mucosal Immunol."},{"issue":"2","key":"10.1016\/j.smim.2021.101482_bib0485","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ajog.2012.11.019","article-title":"Associations between vaginal bacteria and levels of vaginal defensins in pregnant women","volume":"208","author":"Mitchell","year":"2013","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.smim.2021.101482_bib0490","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1742-4690-7-84","article-title":"Innate immunity against HIV: a priority target for HIV prevention research","volume":"7","author":"Borrow","year":"2010","journal-title":"Retrovirology"},{"issue":"1","key":"10.1016\/j.smim.2021.101482_bib0495","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1600-065X.2011.01082.x","article-title":"Alpha-defensins in human innate immunity","volume":"245","author":"Lehrer","year":"2012","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.smim.2021.101482_bib0500","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev-virology-101416-041734","article-title":"Defensins in viral infection and pathogenesis","volume":"4","author":"Holly","year":"2017","journal-title":"Annu. Rev. Virol."},{"issue":"8","key":"10.1016\/j.smim.2021.101482_bib0505","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/00002030-199308000-00019","article-title":"Defensins inhibit HIV replication in vitro","volume":"7","author":"Nakashima","year":"1993","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.smim.2021.101482_bib0510","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/MOH.0000000000000005","article-title":"Defensins in innate immunity","volume":"21","author":"Zhao","year":"2014","journal-title":"Curr. Opin. Hematol."},{"issue":"3","key":"10.1016\/j.smim.2021.101482_bib0515","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1172\/JCI21948","article-title":"Dual role of alpha-defensin-1 in anti-HIV-1 innate immunity","volume":"115","author":"Chang","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.smim.2021.101482_bib0520","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1182\/blood-2006-05-024489","article-title":"Alpha-defensins block the early steps of HIV-1 infection: interference with the binding of gp120 to CD4","volume":"109","author":"Furci","year":"2007","journal-title":"Blood"},{"issue":"27","key":"10.1016\/j.smim.2021.101482_bib0525","doi-asserted-by":"crossref","first-page":"18787","DOI":"10.1074\/jbc.M602422200","article-title":"Theta-defensins prevent HIV-1 Env-mediated fusion by binding gp41 and blocking 6-helix bundle formation","volume":"281","author":"Gallo","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.smim.2021.101482_bib0530","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1097\/00002030-200405210-00020","article-title":"Alpha-defensins inhibit HIV infection of macrophages through upregulation of CC-chemokines","volume":"18","author":"Guo","year":"2004","journal-title":"AIDS"},{"issue":"16","key":"10.1016\/j.smim.2021.101482_bib0535","doi-asserted-by":"crossref","first-page":"F39","DOI":"10.1097\/00002030-200311070-00001","article-title":"Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication","volume":"17","author":"Quinones-Mateu","year":"2003","journal-title":"AIDS"},{"issue":"22","key":"10.1016\/j.smim.2021.101482_bib0540","doi-asserted-by":"crossref","first-page":"14318","DOI":"10.1128\/JVI.79.22.14318-14329.2005","article-title":"Human beta-defensins suppress human immunodeficiency virus infection: potential role in mucosal protection","volume":"79","author":"Sun","year":"2005","journal-title":"J. Virol."},{"issue":"47","key":"10.1016\/j.smim.2021.101482_bib0545","doi-asserted-by":"crossref","first-page":"18631","DOI":"10.1073\/pnas.0702130104","article-title":"Human -defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2","volume":"104","author":"Funderburg","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.smim.2021.101482_bib0550","doi-asserted-by":"crossref","first-page":"6176","DOI":"10.4049\/jimmunol.180.9.6176","article-title":"Neisseria gonorrhoeae-induced human defensins 5 and 6 increase HIV infectivity: role in enhanced transmission","volume":"180","author":"Klotman","year":"2008","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.smim.2021.101482_bib0555","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1172\/JCI114394","article-title":"Monocyte-chemotactic activity of defensins from human neutrophils","volume":"84","author":"Territo","year":"1989","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.smim.2021.101482_bib0560","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1189\/jlb.68.1.9","article-title":"Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells","volume":"68","author":"Yang","year":"2000","journal-title":"J. Leukoc. Biol."},{"issue":"5439","key":"10.1016\/j.smim.2021.101482_bib0565","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1126\/science.286.5439.525","article-title":"Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6","volume":"286","author":"Yang","year":"1999","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.smim.2021.101482_bib0570","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.4049\/jimmunol.179.2.1245","article-title":"A novel role for defensins in intestinal homeostasis: regulation of IL-1beta secretion","volume":"179","author":"Shi","year":"2007","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.smim.2021.101482_bib0575","doi-asserted-by":"crossref","first-page":"e0173161","DOI":"10.1371\/journal.pone.0173161","article-title":"Early type I Interferon response induces upregulation of human beta-defensin 1 during acute HIV-1 infection","volume":"12","author":"Corleis","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.smim.2021.101482_bib0580","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.virol.2015.09.025","article-title":"Human beta-defensins 2 and -3 cointernalize with human immunodeficiency virus via heparan sulfate proteoglycans and reduce infectivity of intracellular virions in tonsil epithelial cells","volume":"487","author":"Herrera","year":"2016","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.smim.2021.101482_bib0585","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/154407370601900109","article-title":"Role of human beta-defensins in HIV infection","volume":"19","author":"Weinberg","year":"2006","journal-title":"Adv. Dent. Res."},{"key":"10.1016\/j.smim.2021.101482_bib0590","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.peptides.2016.06.002","article-title":"Human beta-defensin 3 suppresses Porphyromonas gingivalis lipopolysaccharide-induced inflammation in RAW 264.7 cells and aortas of ApoE-deficient mice","volume":"82","author":"Bian","year":"2016","journal-title":"Peptides"},{"key":"10.1016\/j.smim.2021.101482_bib0595","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cyto.2016.12.015","article-title":"Beta-defensin 3 modulates macrophage activation and orientation during acute inflammatory response to Porphyromonas gingivalis lipopolysaccharide","volume":"92","author":"Lyu","year":"2017","journal-title":"Cytokine"},{"key":"10.1016\/j.smim.2021.101482_bib0600","doi-asserted-by":"crossref","first-page":"8529542","DOI":"10.1155\/2017\/8529542","article-title":"Human beta-defensin 3 reduces TNF-alpha-Induced inflammation and monocyte adhesion in human umbilical vein endothelial cells","volume":"2017","author":"Bian","year":"2017","journal-title":"Mediators Inflamm."},{"issue":"10","key":"10.1016\/j.smim.2021.101482_bib0605","doi-asserted-by":"crossref","first-page":"6432","DOI":"10.1128\/JVI.79.10.6432-6440.2005","article-title":"Human immunodeficiency virus type 1 stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: a role for SLPI in innate mucosal immunity","volume":"79","author":"Jana","year":"2005","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.smim.2021.101482_bib0610","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1084\/jem.20041115","article-title":"Secretory leukocyte protease inhibitor binds to annexin II, a cofactor for macrophage HIV-1 infection","volume":"200","author":"Ma","year":"2004","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.smim.2021.101482_bib0615","doi-asserted-by":"crossref","first-page":"e5006","DOI":"10.1371\/journal.pone.0005006","article-title":"The phospholipid scramblases 1 and 4 are cellular receptors for the secretory leukocyte protease inhibitor and interact with CD4 at the plasma membrane","volume":"4","author":"Py","year":"2009","journal-title":"PLoS One"},{"issue":"13","key":"10.1016\/j.smim.2021.101482_bib0620","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1097\/QAD.0b013e32832ea643","article-title":"Elevated elafin\/trappin-2 in the female genital tract is associated with protection against HIV acquisition","volume":"23","author":"Iqbal","year":"2009","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.smim.2021.101482_bib0625","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nri2302","article-title":"Setting the stage: host invasion by HIV","volume":"8","author":"Hladik","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.smim.2021.101482_bib0630","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.3389\/fimmu.2018.02876","article-title":"Restriction factors: from intrinsic viral restriction to shaping cellular immunity against HIV-1","volume":"9","author":"Colomer-Lluch","year":"2018","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.smim.2021.101482_bib0635","doi-asserted-by":"crossref","first-page":"a006940","DOI":"10.1101\/cshperspect.a006940","article-title":"HIV restriction factors and mechanisms of evasion","volume":"2","author":"Malim","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"1","key":"10.1016\/j.smim.2021.101482_bib0640","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.immuni.2012.04.011","article-title":"Commensal bacteria calibrate the activation threshold of innate antiviral immunity","volume":"37","author":"Abt","year":"2012","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.smim.2021.101482_bib0645","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.immuni.2012.05.020","article-title":"Priming of natural killer cells by nonmucosal mononuclear phagocytes requires instructive signals from commensal microbiota","volume":"37","author":"Ganal","year":"2012","journal-title":"Immunity"},{"issue":"13","key":"10.1016\/j.smim.2021.101482_bib0650","doi-asserted-by":"crossref","first-page":"5354","DOI":"10.1073\/pnas.1019378108","article-title":"Microbiota regulates immune defense against respiratory tract influenza A virus infection","volume":"108","author":"Ichinohe","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2021.101482_bib0655","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.3389\/fphys.2018.01534","article-title":"Mouse microbiota models: comparing germ-free mice and antibiotics treatment as tools for modifying gut Bacteria","volume":"9","author":"Kennedy","year":"2018","journal-title":"Front. Physiol."},{"issue":"11","key":"10.1016\/j.smim.2021.101482_bib0660","doi-asserted-by":"crossref","first-page":"6861","DOI":"10.4049\/jimmunol.178.11.6861","article-title":"CD103- and CD103+ bronchial lymph node dendritic cells are specialized in presenting and cross-presenting innocuous antigen to CD4+ and CD8+ T cells","volume":"178","author":"del Rio","year":"2007","journal-title":"J. Immunol."},{"issue":"5966","key":"10.1016\/j.smim.2021.101482_bib0665","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1126\/science.1178331","article-title":"Development of monocytes, macrophages, and dendritic cells","volume":"327","author":"Geissmann","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.smim.2021.101482_bib0670","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev-immunol-020711-074950","article-title":"The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting","volume":"31","author":"Merad","year":"2013","journal-title":"Annu. Rev. Immunol."},{"issue":"2 Suppl. 2","key":"10.1016\/j.smim.2021.101482_bib0675","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/j.jaci.2009.07.008","article-title":"Immunologic messenger molecules: cytokines, interferons, and chemokines","volume":"125","author":"Commins","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"issue":"25","key":"10.1016\/j.smim.2021.101482_bib0680","doi-asserted-by":"crossref","first-page":"9971","DOI":"10.1073\/pnas.1203543109","article-title":"Regulation of innate CD8+ T-cell activation mediated by cytokines","volume":"109","author":"Freeman","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2021.101482_bib0685","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.coi.2015.06.004","article-title":"HIV and mucosal barrier interactions: consequences for transmission and pathogenesis","volume":"36","author":"Burgener","year":"2015","journal-title":"Curr. Opin. Immunol."},{"issue":"9","key":"10.1016\/j.smim.2021.101482_bib0690","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.4049\/jimmunol.1103014","article-title":"Cutting edge: regulation of intestinal inflammation and barrier function by IL-17C","volume":"189","author":"Reynolds","year":"2012","journal-title":"J. Immunol."},{"issue":"19","key":"10.1016\/j.smim.2021.101482_bib0695","doi-asserted-by":"crossref","first-page":"10843","DOI":"10.1128\/JVI.01838-13","article-title":"Preferential HIV infection of CCR6+ Th17 cells is associated with higher levels of virus receptor expression and lack of CCR5 ligands","volume":"87","author":"Alvarez","year":"2013","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.smim.2021.101482_bib0700","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.chom.2016.03.005","article-title":"Th17 cells are preferentially infected very early after vaginal transmission of SIV in macaques","volume":"19","author":"Stieh","year":"2016","journal-title":"Cell Host Microbe"},{"issue":"326","key":"10.1016\/j.smim.2021.101482_bib0705","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00003086-199605000-00004","article-title":"The immune response: the efferent arm","author":"Horowitz","year":"1996","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"6","key":"10.1016\/j.smim.2021.101482_bib0710","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1084\/jem.189.6.991","article-title":"Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques","volume":"189","author":"Jin","year":"1999","journal-title":"J. Exp. Med."},{"issue":"5403","key":"10.1016\/j.smim.2021.101482_bib0715","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1126\/science.283.5403.857","article-title":"Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes","volume":"283","author":"Schmitz","year":"1999","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.smim.2021.101482_bib0720","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.immuni.2015.08.012","article-title":"Magnitude and kinetics of CD8+ t cell activation during hyperacute HIV infection impact viral set point","volume":"43","author":"Ndhlovu","year":"2015","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.smim.2021.101482_bib0725","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/QAD.0000000000000508","article-title":"Broad and persistent Gag-specific CD8+ T-cell responses are associated with viral control but rarely drive viral escape during primary HIV-1 infection","volume":"29","author":"Radebe","year":"2015","journal-title":"AIDS"},{"issue":"5243","key":"10.1016\/j.smim.2021.101482_bib0730","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1126\/science.270.5243.1811","article-title":"Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells","volume":"270","author":"Cocchi","year":"1995","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.smim.2021.101482_bib0735","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.1128\/JVI.00118-15","article-title":"Increased levels of macrophage inflammatory proteins result in resistance to R5-Tropic HIV-1 in a subset of elite controllers","volume":"89","author":"Walker","year":"2015","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.smim.2021.101482_bib0740","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/QAI.0b013e318189a7ca","article-title":"Bacterial vaginosis in HIV-infected women induces reversible alterations in the cervical immune environment","volume":"49","author":"Rebbapragada","year":"2008","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"8","key":"10.1016\/j.smim.2021.101482_bib0745","doi-asserted-by":"crossref","first-page":"e43951","DOI":"10.1371\/journal.pone.0043951","article-title":"Searching for lower female genital tract soluble and cellular biomarkers: defining levels and predictors in a cohort of healthy Caucasian women","volume":"7","author":"Kyongo","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.smim.2021.101482_bib0750","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nm.4506","article-title":"Genital inflammation undermines the effectiveness of tenofovir gel in preventing HIV acquisition in women","volume":"24","author":"McKinnon","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.smim.2021.101482_bib0755","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/1742-4690-10-141","article-title":"Immune quiescence: a model of protection against HIV infection","volume":"10","author":"Card","year":"2013","journal-title":"Retrovirology"},{"issue":"7","key":"10.1016\/j.smim.2021.101482_bib0760","doi-asserted-by":"crossref","first-page":"e25150","DOI":"10.1002\/jia2.25150","article-title":"Using safe, affordable and accessible non-steroidal anti-inflammatory drugs to reduce the number of HIV target cells in the blood and at the female genital tract","volume":"21","author":"Lajoie","year":"2018","journal-title":"J. Int. AIDS Soc."},{"issue":"1","key":"10.1016\/j.smim.2021.101482_bib0765","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/jim-2020-001424","article-title":"Betamethasone induces potent immunosuppression and reduces HIV infection in a PBMC in vitro model","volume":"69","author":"Cromarty","year":"2021","journal-title":"J. Investig. Med."},{"issue":"9","key":"10.1016\/j.smim.2021.101482_bib0770","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa1507198","article-title":"A trial of early antiretrovirals and isoniazid preventive therapy in Africa","volume":"373","author":"Group","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.smim.2021.101482_bib0775","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1506816","article-title":"Initiation of antiretroviral therapy in early asymptomatic HIV infection","volume":"373","author":"Group","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"9989","key":"10.1016\/j.smim.2021.101482_bib0780","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0140-6736(15)60658-4","article-title":"Defeating AIDS--advancing global health","volume":"386","author":"Piot","year":"2015","journal-title":"Lancet"},{"issue":"5996","key":"10.1016\/j.smim.2021.101482_bib0785","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.1193748","article-title":"Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women","volume":"329","author":"Abdool Karim","year":"2010","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.smim.2021.101482_bib0790","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJMoa1402269","article-title":"Tenofovir-based preexposure prophylaxis for HIV infection among African women","volume":"372","author":"Marrazzo","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.smim.2021.101482_bib0795","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S1473-3099(18)30428-6","article-title":"Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial","volume":"18","author":"Delany-Moretlwe","year":"2018","journal-title":"Lancet Infect. Dis."},{"issue":"3","key":"10.1016\/j.smim.2021.101482_bib0800","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/QAI.0000000000000607","article-title":"Genital tenofovir concentrations correlate with protection against HIV infection in the CAPRISA 004 trial: importance of adherence for microbicide effectiveness","volume":"69","author":"Kashuba","year":"2015","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"22","key":"10.1016\/j.smim.2021.101482_bib0805","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1056\/NEJMoa1506110","article-title":"Use of a vaginal ring containing dapivirine for HIV-1 prevention in women","volume":"375","author":"Baeten","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.smim.2021.101482_bib0810","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1056\/NEJMoa1602046","article-title":"Safety and efficacy of a dapivirine vaginal ring for HIV prevention in women","volume":"375","author":"Nel","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.smim.2021.101482_bib0815","doi-asserted-by":"crossref","first-page":"e25634","DOI":"10.1002\/jia2.25634","article-title":"Greater dapivirine release from the dapivirine vaginal ring is correlated with lower risk of HIV-1 acquisition: a secondary analysis from a randomized, placebo-controlled trial","volume":"23","author":"Brown","year":"2020","journal-title":"J. Int. AIDS Soc."},{"issue":"2","key":"10.1016\/j.smim.2021.101482_bib0820","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1016\/S2352-3018(20)30304-0","article-title":"Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study","volume":"8","author":"Baeten","year":"2021","journal-title":"Lancet HIV"},{"issue":"2","key":"10.1016\/j.smim.2021.101482_bib0825","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1016\/S2352-3018(20)30300-3","article-title":"Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension study","volume":"8","author":"Nel","year":"2021","journal-title":"Lancet HIV"},{"issue":"3","key":"10.1016\/j.smim.2021.101482_bib0830","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/QAD.0000000000002751","article-title":"Influence of dapivirine vaginal ring use on cervicovaginal immunity and functional microbiome in adolescent girls","volume":"35","author":"Farr Zuend","year":"2021","journal-title":"AIDS"},{"issue":"27","key":"10.1016\/j.smim.2021.101482_bib0835","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men","volume":"363","author":"Grant","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.smim.2021.101482_bib0840","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1202614","article-title":"Preexposure prophylaxis for HIV infection among African women","volume":"367","author":"Van Damme","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.smim.2021.101482_bib0845","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJMoa1110711","article-title":"Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana","volume":"367","author":"Thigpen","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.smim.2021.101482_bib0850","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJMoa1108524","article-title":"Antiretroviral prophylaxis for HIV prevention in heterosexual men and women","volume":"367","author":"Baeten","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.smim.2021.101482_bib0855","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1056\/NEJMoa1506273","article-title":"On-demand preexposure prophylaxis in men at high risk for HIV-1 infection","volume":"373","author":"Molina","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"10013","key":"10.1016\/j.smim.2021.101482_bib0860","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(15)00056-2","article-title":"Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial","volume":"387","author":"McCormack","year":"2016","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.smim.2021.101482_bib0865","doi-asserted-by":"crossref","first-page":"F13","DOI":"10.1097\/QAD.0b013e3283522272","article-title":"Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention","volume":"26","author":"van der Straten","year":"2012","journal-title":"AIDS"},{"issue":"11","key":"10.1016\/j.smim.2021.101482_bib0870","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/QAD.0000000000000647","article-title":"Defining success with HIV pre-exposure prophylaxis: a prevention-effective adherence paradigm","volume":"29","author":"Haberer","year":"2015","journal-title":"AIDS"},{"issue":"6341","key":"10.1016\/j.smim.2021.101482_bib0875","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1126\/science.aai9383","article-title":"Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women","volume":"356","author":"Klatt","year":"2017","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.smim.2021.101482_bib0880","doi-asserted-by":"crossref","first-page":"e1009024","DOI":"10.1371\/journal.ppat.1009024","article-title":"Impact of vaginal microbiome communities on HIV antiretroviral-based pre-exposure prophylaxis (PrEP) drug metabolism","volume":"16","author":"Cheu","year":"2020","journal-title":"PLoS Pathog."},{"issue":"7762","key":"10.1016\/j.smim.2021.101482_bib0885","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41586-019-1291-3","article-title":"Mapping human microbiome drug metabolism by gut bacteria and their genes","volume":"570","author":"Zimmermann","year":"2019","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.smim.2021.101482_bib0890","doi-asserted-by":"crossref","first-page":"e449","DOI":"10.1016\/S2352-3018(17)30110-8","article-title":"Efficacy of oral pre-exposure prophylaxis (PrEP) for HIV among women with abnormal vaginal microbiota: a post-hoc analysis of the randomised, placebo-controlled Partners PrEP Study","volume":"4","author":"Heffron","year":"2017","journal-title":"Lancet HIV"},{"issue":"6","key":"10.1016\/j.smim.2021.101482_bib0895","doi-asserted-by":"crossref","first-page":"e0128557","DOI":"10.1371\/journal.pone.0128557","article-title":"Gene expression profiling of human vaginal cells in vitro discriminates compounds with pro-inflammatory and mucosa-altering properties: novel biomarkers for preclinical testing of HIV microbicide candidates","volume":"10","author":"Zalenskaya","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.smim.2021.101482_bib0900","series-title":"StatPearls [Internet]","article-title":"Metronidazole. [Updated 2021 Mar 26]","author":"Weir","year":"2021"},{"key":"10.1016\/j.smim.2021.101482_bib0905","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiv079","article-title":"Rapid and profound shifts in the vaginal microbiota following antibiotic treatment for bacterial vaginosis","author":"Mayer","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.smim.2021.101482_bib0910","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fcimb.2020.00083","article-title":"Gardnerella vaginalis enhances atopobium vaginae viability in an in vitro Model","volume":"10","author":"Castro","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"6369","key":"10.1016\/j.smim.2021.101482_bib0915","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1126\/science.aal5240","article-title":"Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer","volume":"358","author":"Bullman","year":"2017","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.smim.2021.101482_bib0920","doi-asserted-by":"crossref","DOI":"10.1128\/mSphereDirect.00262-18","article-title":"Metatranscriptome analysis of the vaginal microbiota reveals potential mechanisms for protection against metronidazole in bacterial vaginosis","volume":"3","author":"Deng","year":"2018","journal-title":"mSphere"},{"issue":"11","key":"10.1016\/j.smim.2021.101482_bib0925","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1373\/clinchem.2019.305474","article-title":"In silico analysis of Gardnerella genomospecies detected in the setting of bacterial vaginosis","volume":"65","author":"Potter","year":"2019","journal-title":"Clin. Chem."},{"issue":"5 Pt 1","key":"10.1016\/j.smim.2021.101482_bib0930","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/01.AOG.0000183594.45524.d2","article-title":"Adherent biofilms in bacterial vaginosis","volume":"106","author":"Swidsinski","year":"2005","journal-title":"Obstet. Gynecol."},{"issue":"9\u201310","key":"10.1016\/j.smim.2021.101482_bib0935","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.resmic.2017.02.001","article-title":"Bacterial biofilms in the vagina","volume":"168","author":"Hardy","year":"2017","journal-title":"Res. Microbiol."},{"issue":"12","key":"10.1016\/j.smim.2021.101482_bib0940","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1002\/ecy.1601","article-title":"Biodiversity increases functional and compositional resistance, but decreases resilience in phytoplankton communities","volume":"97","author":"Baert","year":"2016","journal-title":"Ecology"},{"issue":"7729","key":"10.1016\/j.smim.2021.101482_bib0945","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41586-018-0627-8","article-title":"Biodiversity increases and decreases ecosystem stability","volume":"563","author":"Pennekamp","year":"2018","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.smim.2021.101482_bib0950","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/s41396-018-0337-0","article-title":"Unveiling the role of Gardnerella vaginalis in polymicrobial Bacterial Vaginosis biofilms: the impact of other vaginal pathogens living as neighbors","volume":"13","author":"Castro","year":"2019","journal-title":"ISME J."},{"issue":"1","key":"10.1016\/j.smim.2021.101482_bib0955","doi-asserted-by":"crossref","first-page":"6147","DOI":"10.1038\/s41467-020-19880-w","article-title":"Quantitative modeling predicts mechanistic links between pre-treatment microbiome composition and metronidazole efficacy in bacterial vaginosis","volume":"11","author":"Lee","year":"2020","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.smim.2021.101482_bib0960","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1099\/jmm.0.000561","article-title":"Treatment failure of bacterial vaginosis is not associated with higher loads of Atopobium vaginae and Gardnerella vaginalis","volume":"66","author":"Ferreira","year":"2017","journal-title":"J. Med. Microbiol."},{"issue":"1","key":"10.1016\/j.smim.2021.101482_bib0965","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens10010054","article-title":"Engineered phage endolysin eliminates gardnerella biofilm without damaging beneficial bacteria in bacterial vaginosis ex vivo","volume":"10","author":"Landlinger","year":"2021","journal-title":"Pathogens"},{"issue":"11","key":"10.1016\/j.smim.2021.101482_bib0970","doi-asserted-by":"crossref","first-page":"e0166757","DOI":"10.1371\/journal.pone.0166757","article-title":"Genomes of gardnerella strains reveal an abundance of prophages within the bladder microbiome","volume":"11","author":"Malki","year":"2016","journal-title":"PLoS One"},{"issue":"20","key":"10.1016\/j.smim.2021.101482_bib0975","doi-asserted-by":"crossref","DOI":"10.1128\/AEM.01594-20","article-title":"Novel selective inhibition of Lactobacillus iners by lactobacillus-derived bacteriocins","volume":"86","author":"Nilsen","year":"2020","journal-title":"Appl. Environ. Microbiol."},{"issue":"5","key":"10.1016\/j.smim.2021.101482_bib0980","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.4049\/jimmunol.1502470","article-title":"Enhancement of microbiota in healthy macaques results in beneficial modulation of mucosal and systemic immune function","volume":"196","author":"Manuzak","year":"2016","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.smim.2021.101482_bib0985","doi-asserted-by":"crossref","first-page":"902","DOI":"10.3390\/app11030902","article-title":"Improvement of bacterial vaginosis by oral Lactobacillus supplement: a randomized, double-blinded trial","volume":"11","author":"Lin","year":"2021","journal-title":"Appl. Sci."},{"issue":"1","key":"10.1016\/j.smim.2021.101482_bib0990","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3920\/BM2017.0018","article-title":"Effect of a yoghurt drink containing Lactobacillus strains on bacterial vaginosis in women - a double-blind, randomised, controlled clinical pilot trial","volume":"9","author":"Laue","year":"2018","journal-title":"Benef. Microbes"},{"issue":"10","key":"10.1016\/j.smim.2021.101482_bib0995","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.resmic.2011.08.003","article-title":"Demonstration of vaginal colonization with GusA-expressing Lactobacillus jensenii following oral delivery in rhesus macaques","volume":"162","author":"Lagenaur","year":"2011","journal-title":"Res. Microbiol."},{"issue":"1","key":"10.1016\/j.smim.2021.101482_bib1000","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1080\/21505594.2018.1464362","article-title":"Saccharomyces cerevisiae-based probiotic as novel anti-microbial agent for therapy of bacterial vaginosis","volume":"9","author":"Sabbatini","year":"2018","journal-title":"Virulence"},{"issue":"9","key":"10.1016\/j.smim.2021.101482_bib1005","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms8091294","article-title":"Anti-biofilm properties of Saccharomyces cerevisiae CNCM I-3856 and Lacticaseibacillus rhamnosus ATCC 53103 probiotics against G. vaginalis","volume":"8","author":"Sabbatini","year":"2020","journal-title":"Microorganisms"},{"issue":"4","key":"10.1016\/j.smim.2021.101482_bib1010","doi-asserted-by":"crossref","first-page":"e0122730","DOI":"10.1371\/journal.pone.0122730","article-title":"Robust vaginal colonization of macaques with a novel vaginally disintegrating tablet containing a live biotherapeutic product to prevent HIV infection in women","volume":"10","author":"Lagenaur","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.smim.2021.101482_bib1015","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1038\/s41598-020-60671-6","article-title":"Intermittent lactobacilli-containing vaginal probiotic or metronidazole use to prevent bacterial vaginosis recurrence: a pilot study incorporating microscopy and sequencing","volume":"10","author":"van de Wijgert","year":"2020","journal-title":"Sci. Rep."},{"issue":"20","key":"10.1016\/j.smim.2021.101482_bib1020","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1056\/NEJMoa1915254","article-title":"Randomized trial of Lactin-V to prevent recurrence of bacterial vaginosis","volume":"382","author":"Cohen","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.smim.2021.101482_bib1025","article-title":"Connecting the dots: translating the vaginal microbiome into a drug","author":"Lagenaur","year":"2020","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.smim.2021.101482_bib1030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.micpath.2018.06.002","article-title":"Bioengineered intravaginal isolate of Lactobacillus plantarum expresses algal lectin scytovirin demonstrating anti-HIV-1 activity","volume":"122","author":"Janahi","year":"2018","journal-title":"Microb. Pathog."},{"issue":"3","key":"10.1016\/j.smim.2021.101482_bib1035","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0361-9230(92)90043-W","article-title":"Differential rearing conditions in rats: effects on neurochemistry in neocortical areas and cognitive behaviors","volume":"28","author":"Myhrer","year":"1992","journal-title":"Brain Res. Bull."},{"issue":"6","key":"10.1016\/j.smim.2021.101482_bib1040","doi-asserted-by":"crossref","first-page":"e1008559","DOI":"10.1371\/journal.ppat.1008559","article-title":"Exploring potential of vaginal Lactobacillus isolates from South African women for enhancing treatment for bacterial vaginosis","volume":"16","author":"Happel","year":"2020","journal-title":"PLoS Pathog."},{"issue":"6","key":"10.1016\/j.smim.2021.101482_bib1045","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/QAD.0000000000001744","article-title":"Plasma and intracellular pharmacokinetics of tenofovir in patients switched from tenofovir disoproxil fumarate to tenofovir alafenamide","volume":"32","author":"Podany","year":"2018","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.smim.2021.101482_bib1050","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/COH.0000000000000599","article-title":"Islatravir for the treatment and prevention of infection with the human immunodeficiency virus type 1","volume":"15","author":"Markowitz","year":"2020","journal-title":"Curr. Opin. HIV AIDS"},{"issue":"11","key":"10.1016\/j.smim.2021.101482_bib1055","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1007\/s10461-017-2017-x","article-title":"Expanding the menu of HIV prevention options: a qualitative study of experiences with long-acting injectable cabotegravir as PrEP in the context of a phase II trial in the United States","volume":"22","author":"Kerrigan","year":"2018","journal-title":"AIDS Behav."},{"issue":"4","key":"10.1016\/j.smim.2021.101482_bib1060","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/15284336.2018.1511346","article-title":"Satisfaction and acceptability of cabotegravir long-acting injectable suspension for prevention of HIV: patient perspectives from the ECLAIR trial","volume":"19","author":"Murray","year":"2018","journal-title":"HIV Clin. Trials"},{"issue":"1","key":"10.1016\/j.smim.2021.101482_bib1065","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/COH.0000000000000597","article-title":"Long-acting injectable cabotegravir for the prevention of HIV infection","volume":"15","author":"Clement","year":"2020","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.smim.2021.101482_bib1070","article-title":"The potential impact of long-acting cabotegravir for HIV prevention in South Africa: a mathematical modelling study","author":"Smith","year":"2020","journal-title":"J. Infect. Dis."}],"container-title":["Seminars in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532321000130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532321000130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T23:21:01Z","timestamp":1760916061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044532321000130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":214,"alternative-id":["S1044532321000130"],"URL":"https:\/\/doi.org\/10.1016\/j.smim.2021.101482","relation":{},"ISSN":["1044-5323"],"issn-type":[{"value":"1044-5323","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microbial mismanagement: how inadequate treatments for vaginal dysbiosis drive the HIV epidemic in women","name":"articletitle","label":"Article Title"},{"value":"Seminars in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.smim.2021.101482","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 University Of Minnesota Twin Cities - Medical School. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101482"}}